Oncotelic Therapeutics (OTLC) Selling, General & Administrative (2010 - 2026)
Oncotelic Therapeutics (OTLC) reported Selling, General & Administrative of $1.09 million for Q2 2026, compared with $65,672 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Oncotelic Therapeutics' Selling, General & Administrative came in at $4.17 million; for FY2025, it came in at $3.18 million, up 746.3% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of -8.7% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $376,013 in FY2024 (-34.5%), $573,726 in FY2023 (-88.2%), $4.85 million in FY2022 (-11.2%) and $5.47 million in FY2021 (+8.8%).
- Five-year quarterly Selling, General & Administrative spans a low of $32,666 in Q4 2024 and a high of $3.76 million in Q1 2022.
- Year over year, Selling, General & Administrative gained in two of the last five quarters, with growth averaging 101.1%.
- The high point for year-over-year Selling, General & Administrative in five years was Q1 2022 (growth of 682.2%); the low point was Q2 2022 (a decline of 94.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 1.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Dec 31, 2025 | 2.53 Mn |
| Sep 30, 2025 | 490,547.00 |
| Jun 30, 2025 | 65,672.00 |
| Mar 31, 2025 | 100,803.00 |
| Dec 31, 2024 | 32,666.00 |
| Sep 30, 2024 | 80,277.00 |
| Jun 30, 2024 | 96,330.00 |
| Mar 31, 2024 | 166,742.00 |
| Dec 31, 2023 | 102,468.00 |
| Sep 30, 2023 | 34,301.00 |
| Jun 30, 2023 | 238,758.00 |
| Mar 31, 2023 | 198,200.00 |
| Dec 31, 2022 | 348,408.00 |
| Sep 30, 2022 | 593,739.00 |
| Jun 30, 2022 | 147,608.00 |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 991,624.00 |
| Sep 30, 2021 | 1.19 Mn |
| Jun 30, 2021 | 2.81 Mn |
API Access
Oncotelic Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();